Analysts at InCred Equities said they are disappointed with the repeated delay in Cenexi's turnaround and will reassess the ...

Abelacimab is a fully human monoclonal antibody that binds to the inactive form of factor XI and blocks its activation. The safety of abelacimab as compared with a direct oral anticoagulant in ...

Ltd (GLAND:IN), raising the stock rating from Reduce to Neutral. The firm also adjusted the price target slightly to INR 1,790.00, down from the previous INR 1,800.00. Nomura analysts cited a mix of ...